CD4 and neoplasm: In contrast, AFP-specific CD4 T-cell responses are only detected in HCC patients and response was mainly detected in Okuda tumour stage I HCC patients (58.3%) and to a lesser extent in Okuda tumour stage II or III HCC patients (15.8%) (Figure 4B).